Literature DB >> 28329246

Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.

Po-Kuei Hsu1,2, Ling-I Chien3, Lei-Chi Wang4, Teh-Ying Chou2,4,5.   

Abstract

OBJECTIVES: Patients with oesophageal squamous cell carcinoma have a high risk of disease recurrence even after trimodality treatments, which include preoperative chemoradiotherapy and oesophagectomy. We aimed to identify the histological factors that are associated with loco-regional and distant recurrence.
METHODS: A retrospective review of a prospectively established database identified patients who received preoperative chemoradiotherapy and oesophagectomy for squamous cell carcinoma. The impact of histological factors, including surgical resection margins, lymphovascular invasion (LVI), perineural invasion (PNI), extracapsular invasion (ECI) and tumour regression grade (TRG), on disease recurrence was analysed.
RESULTS: A total of 116 patients treated between 2009 and 2015 were included. Sixty-one patients developed disease recurrence, including 25 loco-regional and 49 distant recurrences, with a median disease-free interval of 6 months. Positive histological surgical resection margins were significantly associated with loco-regional recurrence, whereas pre-treatment N stage, ypT stage, ypN stage, positive surgical resection margins, TRG, LVI, PNI, ECI and TRG were significant prognostic factors for distant recurrence. Upon multivariate analysis, cN stage [hazard ratio (HR): 4.049; 95% confidence interval (CI): 1.242-13.200, P  = 0.020], LVI (HR: 3.658; 95% CI: 1.891-7.078, P  < 0.001) and ECI (HR: 2.393; 95% CI: 1.202-4.763, P  = 0.013) remained independent factors for distant recurrence. The 1- and 3-year freedom from distant recurrence rates were 71.8 and 65.6%, respectively, when both LVI and ECI factors were absent, compared to 17.6 and 14.1% when either or both were present ( P  < 0.001).
CONCLUSIONS: Patients with lymphovascular invasion and extracapsular invasion are at a high risk of distant recurrence after preoperative chemoradiotherapy and oesophagectomy. Effective systemic therapy and intensive surveillance are necessary in this group of patients.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy ; Oesophageal cancer ; Recurrence

Mesh:

Year:  2017        PMID: 28329246     DOI: 10.1093/ejcts/ezx029

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Can lymphovascular invasion be predicted by contrast-enhanced CT imaging features in patients with esophageal squamous cell carcinoma? A preliminary retrospective study.

Authors:  Yang Li; Haiyan Su; Li Yang; Meng Yue; Mingbo Wang; Xiaolong Gu; Lijuan Dai; Xiangming Wang; Xiaohua Su; Andu Zhang; Jialiang Ren; Gaofeng Shi
Journal:  BMC Med Imaging       Date:  2022-05-17       Impact factor: 2.795

2.  Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.

Authors:  Hesong Shen; Yuanying Huang; Xiaoqian Yuan; Daihong Liu; Chunrong Tu; Yu Wang; Xiaoqin Li; Xiaoxia Wang; Qiuzhi Chen; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-02

3.  Predicting aggressive histopathological features in esophageal cancer with positron emission tomography using a deep convolutional neural network.

Authors:  Joe Chao-Yuan Yeh; Wei-Hsiang Yu; Cheng-Kun Yang; Ling-I Chien; Ko-Han Lin; Wen-Sheng Huang; Po-Kuei Hsu
Journal:  Ann Transl Med       Date:  2021-01

4.  Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery.

Authors:  Chengbin Zheng; Xingyu Feng; Jiabin Zheng; Qian Yan; Xu Hu; Huolun Feng; Zhenru Deng; Qianchao Liao; Junjiang Wang; Yong Li
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

5.  The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma.

Authors:  Yu Ma; Xi Yao; Zhenzhen Li; Jie Chen; Wensheng Li; Hongtao Wang; Lanjun Zhang; Jianfei Zhu
Journal:  World J Surg Oncol       Date:  2022-01-10       Impact factor: 2.754

6.  Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy.

Authors:  Sho Okuda; Kenoki Ohuchida; Koji Shindo; Taiki Moriyama; Jun Kawata; Koji Tamura; Masafumi Sada; Kinuko Nagayoshi; Yusuke Mizuuchi; Naoki Ikenaga; Kohei Nakata; Yoshinao Oda; Masafumi Nakamura
Journal:  Oncol Lett       Date:  2022-08-11       Impact factor: 3.111

7.  Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.

Authors:  Renma Ito; Yoshiaki Nakamura; Hironori Sunakawa; Hisashi Fujiwara; Hidehiro Hojo; Naoki Nakamura; Takeo Fujita; Tomonori Yano; Hiroyuki Daiko; Tetsuo Akimoto; Takayuki Yoshino; Takashi Kojima
Journal:  Esophagus       Date:  2022-07-28       Impact factor: 3.671

8.  Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.

Authors:  Yang Li; Meng Yu; Guangda Wang; Li Yang; Chongfei Ma; Mingbo Wang; Meng Yue; Mengdi Cong; Jialiang Ren; Gaofeng Shi
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.